Nicaragua Pharmaceuticals & Healthcare Q1 2021

Nicaragua Pharmaceuticals & Healthcare Q1 2021

Key View:

Nicaragua's economy is set to struggle further during the latter part of 2020 and going into 2021 due to combinedeffects of the Covid-19 pandemic and hurricanes Eta and Iota. This will put pressure on healthcare spending capabilities, likelyresulting in a loss of funding for previously agreed healthcare projects and meaning healthcare spending and coverage will remainminimal even as the population often struggles to secure satisfactory healthcare and medicines, particularly in the many rural areasof the country. Despite this, we continue to forecast healthcare and pharmaceutical spending will expand over our forecast period.However, while there are undoubtedly potential long-term opportunities arising from a growing chronic disease burden, Nicaraguawill remain among the least attractive markets for innovative drugmakers, due to its small market size and low average purchasingpower.


Key View
Nicaragua Pharmaceutical & Healthcare Covid-19 Impact
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Americas Innovative Pharmaceuticals Risk/Reward Index
Nicaragua Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Nicaragua Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook